×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [39]
内容类型
期刊论文 [36]
会议论文 [3]
发表日期
2019 [4]
2018 [7]
2017 [7]
2016 [7]
2015 [6]
2014 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共39条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high-risk HPV-positive women
期刊论文
2019, 卷号: 8, 期号: 10, 页码: 4845-4851
作者:
Chen Xiaojun
;
Wei Sun
;
Ma Hongxia
;
Jin Guangfu
;
Hu Zhibin
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
biomarker
cervical cancer
human papillomavirus
telomere
Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety
期刊论文
2019, 卷号: 13, 期号: 3, 页码: 344-353
作者:
Huang, Xiaojun
;
Jiang, Qian
;
Hu, Jianda
;
Li, Jianyong
;
Jin, Jie
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2020/01/03
chronic myeloid leukemia (CML)
dasatinib
tyrosine kinase inhibitor
long-term follow-up
Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China A Randomized Clinical Trial
期刊论文
2019, 卷号: 4, 期号: 5, 页码: 418-427
作者:
Wu, Yangfeng
;
Li, Shenshen
;
Patel, Anushka
;
Li, Xian
;
Du, Xin
收藏
  |  
浏览/下载:219/0
  |  
提交时间:2020/01/03
Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study
期刊论文
2019, 卷号: 257, 期号: 3, 页码: 529-541
作者:
Li, Xiaoxin
;
Dai, Hong
;
Li, Xiaorong
;
Han, Mei
;
Li, Jun
收藏
  |  
浏览/下载:172/0
  |  
提交时间:2020/01/03
Anti-vascular endothelial growth factor
Diabetic macular edema
Pro re nata
Ranibizumab
Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China
期刊论文
2018, 卷号: 24, 页码: 5258-5270
作者:
Zhang, Xiaohui
;
Hu, Jiong
;
Hu, Yu
;
Huang, He
;
Jin, Jie
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/01/03
Antifungal Agents
Fruiting Bodies
Fungal
Hematologic Neoplasms
The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China
期刊论文
2018, 卷号: 438, 页码: 63-75
作者:
Wang, Yu
;
Chen, Hu
;
Chen, Jing
;
Han, Mingzhe
;
Hu, JianDa
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
Minimal residual disease
Donor lymphocyte infusion
Targeted therapy
Acute leukemia
Myelodysplastic syndrome
Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study
期刊论文
2018, 卷号: 52, 期号: 6
作者:
Gao, Lei
;
Zhang, Haoran
;
Xin, Henan
;
Liu, Jianmin
;
Pan, Shouguo
收藏
  |  
浏览/下载:57/0
  |  
提交时间:2020/01/03
Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance
期刊论文
2018, 卷号: 8, 期号: 7, 页码: 61
作者:
Zhang, Jingru
;
Wang, Yingqiao
;
Wang, Jianxiang
;
Hu, Jianda
;
Chen, Suning
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study
期刊论文
2018, 卷号: 7, 期号: 4, 页码: 1043-1055
作者:
Huang, Xiaojun
;
Qiu, Lugui
;
Jin, Jie
;
Zhou, Daobin
;
Chen, Xiequn
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/03
Asia-Pacific
chronic lymphocytic leukemia
ibrutinib
rituximab
small lymphocytic lymphoma
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology
期刊论文
2018, 卷号: 11, 期号: 1, 页码: 33
作者:
Xu, Lanping
;
Chen, Hu
;
Chen, Jing
;
Han, Mingzhe
;
Huang, He
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
Consensus
Allogeneic hematopoietic transplantation
China
Indication
Conditioning regimen
Donor selection
Standard of care
©版权所有 ©2017 CSpace - Powered by
CSpace